Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on March 11, 2019. The filing serves to announce the company's financial performance for the fourth fiscal quarter and the full fiscal year ended December 31, 2018. The registrant is incorporated in Delaware and maintains its principal executive offices in Irvine, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release furnished as Exhibit 99.1, which is not included in the provided text.
Material Changes
The filing does not contain specific data regarding material changes versus prior periods. It solely references the issuance of a press release containing the fourth-quarter and full-year 2018 results.
Guidance, Outlook, and Disclosures
- Regulation FD Disclosure: The company posted an updated investor presentation to its website, furnished as Exhibit 99.2, which may be used in conversations with analysts and investors.
- Legal Status of Information: The information in Item 2.02 and Item 7.01, including the attached exhibits, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
- Emerging Growth Company: The filing indicates the registrant is an emerging growth company but does not specify if it has elected not to use the extended transition period for new accounting standards.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2018.
- Examine Exhibit 99.2 (Investor Presentation) for management's outlook and strategic updates.
- Verify the company's liquidity position and debt obligations, as these are not detailed in the 8-K text itself.
- Confirm whether the company has elected to use the extended transition period for accounting standards as an emerging growth company.